A systematic review of outcomes after thermal and nonthermal partial prostate ablation
We sought to compare oncologic and functional outcomes between thermal and nonthermal energy partial gland ablation (PGA) modalities. We conducted comprehensive, structured literature searches, and 39 papers, abstracts, and presentations met the inclusion criteria of pre-PGA magnetic resonance imagi...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2021-12-01
|
| Series: | Prostate International |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2287888221000210 |
| _version_ | 1797723810030419968 |
|---|---|
| author | Jonathan S. Fainberg Bashir Al Hussein Al Awamlh Antonio Primo DeRosa Gregory T. Chesnut Jonathan A. Coleman Taehyoung Lee Behfar Ehdaie |
| author_facet | Jonathan S. Fainberg Bashir Al Hussein Al Awamlh Antonio Primo DeRosa Gregory T. Chesnut Jonathan A. Coleman Taehyoung Lee Behfar Ehdaie |
| author_sort | Jonathan S. Fainberg |
| collection | DOAJ |
| description | We sought to compare oncologic and functional outcomes between thermal and nonthermal energy partial gland ablation (PGA) modalities. We conducted comprehensive, structured literature searches, and 39 papers, abstracts, and presentations met the inclusion criteria of pre-PGA magnetic resonance imaging, oncologic outcomes of at least 6 months, and systematic biopsies after PGA. Twenty-six studies used thermal ablation: high-intensity focused ultrasound (HIFU), cryotherapy, focal laser ablation, or radiofrequency ablation. In-field recurrence rates ranged from 0 to 36% for HIFU, 6 to 24% for cryotherapy, 4 to 50% for focal laser ablation, and 20 to 25% for radiofrequency ablation. Twelve studies used nonthermal technologies of focal brachytherapy, vascular-targeted photodynamic therapy, or irreversible electroporation. Focal brachytherapy had the lowest reported failure rate of 8%, vascular-targeted photodynamic therapy had >30% positive in-field biopsies, and irreversible electroporation had in-field recurrence rates of 12–35%. PGA was well tolerated, and nearly all patients returned to baseline urinary function 12 months later. Most modalities caused transient decreases in erectile function. Persistent erectile dysfunction was highest in patients who underwent HIFU. Although oncologic outcomes vary between treatment modalities, systematic review of existing data demonstrates that PGA is a safe treatment option for patients with localized prostate cancer. |
| first_indexed | 2024-03-12T10:07:58Z |
| format | Article |
| id | doaj.art-ede61eeb037d4b219bbc02f8c756c6ac |
| institution | Directory Open Access Journal |
| issn | 2287-8882 |
| language | English |
| last_indexed | 2024-03-12T10:07:58Z |
| publishDate | 2021-12-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Prostate International |
| spelling | doaj.art-ede61eeb037d4b219bbc02f8c756c6ac2023-09-02T11:10:50ZengElsevierProstate International2287-88822021-12-0194169175A systematic review of outcomes after thermal and nonthermal partial prostate ablationJonathan S. Fainberg0Bashir Al Hussein Al Awamlh1Antonio Primo DeRosa2Gregory T. Chesnut3Jonathan A. Coleman4Taehyoung Lee5Behfar Ehdaie6Department of Urology, Weill Cornell Medicine, New York, NY, USA; Corresponding author. 1275 York Avenue, New York, NY 10065, USA.Department of Urology, Weill Cornell Medicine, New York, NY, USASamuel J. Wood Library, Weill Cornell Medicine, New York, NY, USAUrology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USAUrology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USAUrology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USAUrology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USAWe sought to compare oncologic and functional outcomes between thermal and nonthermal energy partial gland ablation (PGA) modalities. We conducted comprehensive, structured literature searches, and 39 papers, abstracts, and presentations met the inclusion criteria of pre-PGA magnetic resonance imaging, oncologic outcomes of at least 6 months, and systematic biopsies after PGA. Twenty-six studies used thermal ablation: high-intensity focused ultrasound (HIFU), cryotherapy, focal laser ablation, or radiofrequency ablation. In-field recurrence rates ranged from 0 to 36% for HIFU, 6 to 24% for cryotherapy, 4 to 50% for focal laser ablation, and 20 to 25% for radiofrequency ablation. Twelve studies used nonthermal technologies of focal brachytherapy, vascular-targeted photodynamic therapy, or irreversible electroporation. Focal brachytherapy had the lowest reported failure rate of 8%, vascular-targeted photodynamic therapy had >30% positive in-field biopsies, and irreversible electroporation had in-field recurrence rates of 12–35%. PGA was well tolerated, and nearly all patients returned to baseline urinary function 12 months later. Most modalities caused transient decreases in erectile function. Persistent erectile dysfunction was highest in patients who underwent HIFU. Although oncologic outcomes vary between treatment modalities, systematic review of existing data demonstrates that PGA is a safe treatment option for patients with localized prostate cancer.http://www.sciencedirect.com/science/article/pii/S2287888221000210Focal therapyNon-thermalPartial gland ablationProstate cancerThermal |
| spellingShingle | Jonathan S. Fainberg Bashir Al Hussein Al Awamlh Antonio Primo DeRosa Gregory T. Chesnut Jonathan A. Coleman Taehyoung Lee Behfar Ehdaie A systematic review of outcomes after thermal and nonthermal partial prostate ablation Prostate International Focal therapy Non-thermal Partial gland ablation Prostate cancer Thermal |
| title | A systematic review of outcomes after thermal and nonthermal partial prostate ablation |
| title_full | A systematic review of outcomes after thermal and nonthermal partial prostate ablation |
| title_fullStr | A systematic review of outcomes after thermal and nonthermal partial prostate ablation |
| title_full_unstemmed | A systematic review of outcomes after thermal and nonthermal partial prostate ablation |
| title_short | A systematic review of outcomes after thermal and nonthermal partial prostate ablation |
| title_sort | systematic review of outcomes after thermal and nonthermal partial prostate ablation |
| topic | Focal therapy Non-thermal Partial gland ablation Prostate cancer Thermal |
| url | http://www.sciencedirect.com/science/article/pii/S2287888221000210 |
| work_keys_str_mv | AT jonathansfainberg asystematicreviewofoutcomesafterthermalandnonthermalpartialprostateablation AT bashiralhusseinalawamlh asystematicreviewofoutcomesafterthermalandnonthermalpartialprostateablation AT antonioprimoderosa asystematicreviewofoutcomesafterthermalandnonthermalpartialprostateablation AT gregorytchesnut asystematicreviewofoutcomesafterthermalandnonthermalpartialprostateablation AT jonathanacoleman asystematicreviewofoutcomesafterthermalandnonthermalpartialprostateablation AT taehyounglee asystematicreviewofoutcomesafterthermalandnonthermalpartialprostateablation AT behfarehdaie asystematicreviewofoutcomesafterthermalandnonthermalpartialprostateablation AT jonathansfainberg systematicreviewofoutcomesafterthermalandnonthermalpartialprostateablation AT bashiralhusseinalawamlh systematicreviewofoutcomesafterthermalandnonthermalpartialprostateablation AT antonioprimoderosa systematicreviewofoutcomesafterthermalandnonthermalpartialprostateablation AT gregorytchesnut systematicreviewofoutcomesafterthermalandnonthermalpartialprostateablation AT jonathanacoleman systematicreviewofoutcomesafterthermalandnonthermalpartialprostateablation AT taehyounglee systematicreviewofoutcomesafterthermalandnonthermalpartialprostateablation AT behfarehdaie systematicreviewofoutcomesafterthermalandnonthermalpartialprostateablation |